The Price section compares costs of the same generic drugs across brands and is purely for information purpose. Medindia neither buys nor sells drugs. Aripiprazole (Apicord (10 mg)) is an atypical ...

Aripiprazole (Arize (10 mg)) is an atypical antipsychotic and antidepressant, prescribed for schizophrenia and depression. It regulates abnormal conditions like disturbed or unusual thinking, loss of ...

Dosage for Abilify (aripiprazole) may vary based on the condition it’s being used to treat. Your doctor may adjust your dosing of Abilify over the course of your treatment. The active ingredient in ...

ABILIFY was initiated at a starting dose of 2 mg/day and titrated to the target dose of 10 mg/day or 30 mg/day. The primary efficacy endpoint was the mean change in the Y-MRS Total Score from baseline ...

This trial was sponsored by Otsuka Pharmaceutical Co. Initially approved in November, over ABILIFY Tablets should be taken once daily with or without food and are available in 2 mg, 5 mg, 10 mg, 15 mg ...

9月6日，CDE新增了阿立哌唑口溶膜(化药2.2类）、注射用紫杉醇聚合物胶束（化药2.2类）、甲磺酸达拉非尼胶囊（化药5.1类）、羟乙磺酸达尔西利片（化药1类）、依维莫司片（化药5.1类）、钇[90Y]树脂微球（化药5.1类）等16个申请上市技术审评报告。 截至2022年9月7 ...

本研究通过双盲交叉试验，首次证实抗精神病药物amisulpride（D2/D3拮抗剂）和aripiprazole（D2/D3部分激动剂）的7天持续给药会特异 ...

It is used to treat adults and adolescents aged 15 years and older who suffer from a disease characterised by symptoms such as hearing, seeing or sensing things which are not there, suspiciousness, ...

TOKYO, JAPAN and PRINCETON, NJ, Nov. 6, 2007 -- Otsuka Pharmaceutical Co., Ltd. and Bristol-Myers Squibb Company (NYSE: BMY) announced today that the U.S. Food and Drug Administration (FDA) approved ...

Oct. 13, 2004 (Stockholm) — The atypical antipsychotic aripiprazole (Abilify) is as effective as haloperidol and significantly more effective than placebo at treating acute agitation in psychotic ...

There were also statistically significant increases in weight and BMI measurements in the aripiprazole 10 mg treatment arm at week 12 using the last observation carried forward analysis for the 10–12 ...

The manufacturer presented direct clinical-effectiveness evidence from 2 randomised controlled trials comparing aripiprazole with placebo and performed a meta-analysis of these trials. The ...